IE35018B1 - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
IE35018B1
IE35018B1 IE329/71A IE32971A IE35018B1 IE 35018 B1 IE35018 B1 IE 35018B1 IE 329/71 A IE329/71 A IE 329/71A IE 32971 A IE32971 A IE 32971A IE 35018 B1 IE35018 B1 IE 35018B1
Authority
IE
Ireland
Prior art keywords
glycoside
sitosterol
pharmaceutically acceptable
therapeutic compositions
compositions
Prior art date
Application number
IE329/71A
Other versions
IE35018L (en
Original Assignee
Liebenberg R W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA701861A external-priority patent/ZA701861B/en
Application filed by Liebenberg R W filed Critical Liebenberg R W
Publication of IE35018L publication Critical patent/IE35018L/en
Publication of IE35018B1 publication Critical patent/IE35018B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Abstract

1298047 Therapeutic compositions R W LIEBENBERG 19 April 1971 [18 March 1970 14 Aug 1970] 24417/71 Heading A5B Therapeutic compositions, having anti-inflammatory, hormonal, reactivating, conditioning and diuretic activity useful in the treatment of arthritis, cholesterosis, arteriosclerosis, and urogenital. diseases due to pathological conditions of the prostate gland, bladder and urinary tract, comprise either a glycoside or glycoside ester of #-sitosterol and a pharmaceutically acceptable solid or emulsion carrier, or a suspension of a glycoside or glycoside ester of #-sitosterol in a pharmaceutically acceptable liquid carrier. The active component is preferably #-sitosterol-#-D-glucoside. The compositions may be administered orally or parenterally in the form of tablets, capsules or processed food. [GB1298047A]
IE329/71A 1970-03-18 1971-03-15 Therapeutic agent IE35018B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA701861A ZA701861B (en) 1970-03-18 1970-03-18 Therapeutic agent
ZA705627 1970-08-14

Publications (2)

Publication Number Publication Date
IE35018L IE35018L (en) 1971-09-18
IE35018B1 true IE35018B1 (en) 1975-10-15

Family

ID=27131005

Family Applications (1)

Application Number Title Priority Date Filing Date
IE329/71A IE35018B1 (en) 1970-03-18 1971-03-15 Therapeutic agent

Country Status (7)

Country Link
BE (1) BE764305A (en)
CA (1) CA973095A (en)
DE (1) DE2113215C2 (en)
FR (1) FR2085718B1 (en)
GB (1) GB1298047A (en)
IE (1) IE35018B1 (en)
IL (1) IL36438A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA721855B (en) * 1972-03-17 1973-05-30 Liebenberg R W Extraction of sterolins from plant material
JPS5123254A (en) * 1974-08-14 1976-02-24 Nippon Shinyaku Co Ltd Suteriru beetaa dd gurukoshidono parumichinsanesuteruno seizohoho
GB1468473A (en) * 1974-08-14 1977-03-30 Nippon Shinyaku Co Ltd Method for the preparation of steryl beta-d-glucoside palmitates
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
FR2312257A1 (en) * 1975-05-28 1976-12-24 Nippon Shinyaku Co Ltd Steryl beta-D-glucoside medicaments - with haemostatic, vascular-strengthening and anti-shock activity
DE2659466A1 (en) * 1976-12-30 1979-02-15 Roecar Holdings Nv STEROLINE AND THEIR USE
DE2759171A1 (en) * 1977-12-31 1979-07-12 Roecar Holdings Nv MEDICINAL PRODUCTS WITH EFFECT AS PROSTAGLANDIN SYNTHETASE INHIBITOR
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
DE3401178A1 (en) * 1984-01-14 1985-07-18 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen USE OF PHYTOSTEROL GLYCOSIDES FOR TREATING INCREASED 5 (6) (ALPHA) EPOXICHOLESTEROL LEVELS
DE3416112A1 (en) * 1984-04-30 1985-10-31 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen USE OF STEROLINES AND SPIROKETALINES AS LIPOXYGENAS REGULATORS
ATE142883T1 (en) * 1991-03-28 1996-10-15 Rooperol Na Nv COMPOSITIONS OF PHYTOSTEROLS WITH PHYTOSTEROLINS AS IMMUNE MODULATORS
US5998396A (en) * 1996-11-05 1999-12-07 Riken Vitamin Co., Ltd. Oil solubilized solutions and foods containing phytosterols and process for their production
FI974648A (en) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroxy acid, lactic acid and hydroxyalkanoate esters and their uses
US6267963B1 (en) * 1999-06-02 2001-07-31 Kraft Foods, Inc. Plant sterol-emulsifier complexes
US6190720B1 (en) * 1999-06-15 2001-02-20 Opta Food Ingredients, Inc. Dispersible sterol compositions
AU1122301A (en) * 1999-11-01 2001-05-14 Forbes Medi-Tech Inc. Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177645A (en) * 1966-06-10 1970-01-14 Lab Du Dr Debat Plant Extracts and Compositions Containing Same.
GB1248684A (en) * 1969-01-31 1971-10-06 Inst Rech S Chimiques Et Biolo Medicinal extracts of plants of the genus prunus and a method of obtaining them

Also Published As

Publication number Publication date
FR2085718B1 (en) 1974-08-30
IL36438A0 (en) 1971-05-26
IL36438A (en) 1974-11-29
DE2113215C2 (en) 1985-03-21
CA973095A (en) 1975-08-19
FR2085718A1 (en) 1971-12-31
GB1298047A (en) 1972-11-29
BE764305A (en) 1971-08-16
DE2113215A1 (en) 1971-10-07
IE35018L (en) 1971-09-18

Similar Documents

Publication Publication Date Title
IE35018B1 (en) Therapeutic agent
US4415554A (en) Treatment for menstrual disorders
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
US3324002A (en) Anti-inflammatory preparations containing proteolytic enzymes and adrenal glucocorticoids
GB1464388A (en) Preparations containing microencapsulated substances and process
CA998860A (en) Cold pilger rolling mill and method for the rolling of tubes
GB1502873A (en) Pharmaceutical compositions with ulcer healing activity
GB1402691A (en) Composition of 4-biphenyl acetic acid
Szekely et al. Effects of calcium chelation on digitalis-induced cardiac arrhythmias
GB1287602A (en) 4,6-DICHLORO-Delta<4.6>-OESTRADIENES
GB1483650A (en) Pharmaceutical preparations based on mesterolone
GB1381426A (en) Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents
GB1388856A (en) Fibrinolytic activators comprising derivatives of phenyl benzoate
GB1302266A (en)
FR2377201A1 (en) Anti inflammatory and vasculotropic compsns. - contg. a synergistic combination of proteolytic enzyme, Ruscus Aculeatus extract and vitamin P
US3715349A (en) 17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid gamma-lactone
JPS5522641A (en) Antiallergic agent
GB1375806A (en)
IE35711L (en) Pharmaceutical compositions
FR2097045A1 (en) 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders
GB1191180A (en) Therapeutic Composition
GB1269616A (en) Improvements in pharmaceutical compositions
IL43236A (en) 15alpha,16alpha-methylene-19-nor-delta4-pregnene-3,20-diones
NL6902213A (en) 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1